FindTrial
Sign In

A study that evaluates the influence of an exercise program guided and structured combined with sleep hygiene measures on the metabolic changes, sleep disturbances and quality of life in patients with type 2 diabetes.

A Randomized study on the effects of sleep hygiene in glycemic control in patients with type 2 diabetes mellitus - DPAF: Diabetes and Physical Activity in Fortaleza

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-8nb7xf
Enrollment
Unknown
Registered
2012-02-01
Start date
2010-12-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes, disorders of sleep, daytime sleepiness, depression, restless legs syndrome and sedentarism.

Interventions

E00-E90
The experimental group will receive the study treatment guidelines regarding sleep hygiene measures. These measures are absolutely not to do naps (can negotiate 15 to 30 minutes), avoiding caffeine, n
behavioural
other

Sponsors

UFC- Universidade Federal do Ceará
Lead Sponsor
UFC- Universidade Federal do Ceará
Collaborator
CIDH- Centro Integrado de Diabetes e Hipertensão
Collaborator

Eligibility

Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Know diagnosed type 2 diabetes for at least 6 months. Men and Woman. Aged between 40 and 60 years. Sign the consent term.

Exclusion criteria

Exclusion criteria: Shift workers Drug abuse Hospitalization (past 30 days) Severe comorbities (renal or hepatic impairment, advanced neoplasia, severe heart failure, severe neurological disorder)

Design outcomes

Primary

MeasureTime frame
Evaluate sleep disturbances through the validation of questionnaires (Index of Pittsburgh sleep quality, the Epworth Sleepiness Scale, Questionnaire on Restless Legs, Berlin Questionnaire, the Beck Depression Inventory, quality of life questionnaire SF-36 Questionnaire level of physical activity-IPAC) used and some inflammatory parameters (interleukin-1, interleukin-6, C-reactive protein, TNF-alpha, visfatin). in patients with type 2 diabetes in both groups by ELISA biochemical methods.—

Secondary

MeasureTime frame
Evaluate if anthropometrical measurements as: Body-Mass Index (BMI): weight divided by height squared Body-fat index (TCI): the circumference of the hips (cm) -18 / height x square root of time Conicity index (CI): Waist circumference (m) / 0.109 x ROOT (body mass / height) Waist / Hip: Waist circumference (cm) / hip circumference (cm).—

Countries

Brazil

Contacts

Public ContactThiago Daniele

UFC- Universidade Federal do Ceará

danielethiago@yahoo.com.br(85) 96477428 - (85) 88038150

Outcome results

None listed

Source: REBEC (via WHO ICTRP)